Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Syncona Shs GBP ( (GB:SYNC) ) has provided an announcement.
Syncona Limited announced the purchase of 129,000 of its ordinary shares as part of its ongoing share buyback program, with the shares to be held in treasury. This transaction affects the company’s issued ordinary share capital and total voting rights, which shareholders can use for regulatory compliance related to the FCA’s Disclosure Guidance and Transparency Rules.
More about Syncona Shs GBP
Syncona is a prominent life science investor dedicated to creating, building, and scaling globally leading life science companies. They focus on developing transformational treatments in areas with high unmet medical needs, working closely with academic founders and experienced management teams to deliver significant patient impact. The company aims to maintain a diversified portfolio of 20-25 life science businesses across various development stages, modalities, and therapeutic areas, with a long-term strategy supported by a robust balance sheet.
YTD Price Performance: -8.43%
Average Trading Volume: 709,820
Technical Sentiment Consensus Rating: Buy
See more data about SYNC stock on TipRanks’ Stock Analysis page.
